.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Moodys
UBS
McKinsey
McKesson
Fish and Richardson
Federal Trade Commission
QuintilesIMS
Novartis

Generated: September 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020137

« Back to Dashboard
NDA 020137 describes DEMADEX, which is a drug marketed by Mylan Speciality Lp and Roche and is included in two NDAs. It is available from two suppliers. Additional details are available on the DEMADEX profile page.

The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.

Summary for NDA: 020137

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 23, 1993TE:RLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 23, 1993TE:RLD:Yes

Expired Orange Book Patents for NDA: 020137

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
Roche
DEMADEX
torsemide
INJECTABLE;INJECTION020137-002Aug 23, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Medtronic
Queensland Health
McKinsey
Cantor Fitzgerald
Fuji
Citi
Dow
Argus Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot